These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5308767)

  • 1. [Clinical data on a drug with a base of gamma-aminobutyric acid and vitamin B6 in the treatment of cerebral paralysis, oligophrenia and behavior disorders in children].
    Hoineff S
    Hospital (Rio J); 1968 May; 73(5):1653-7. PubMed ID: 5308767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of gamma-aminobutyric acid combined with vitamin B6 in mentally retarded children].
    Campos Júnior Mde S
    Hospital (Rio J); 1968 May; 73(5):1647-51. PubMed ID: 5308766
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with clinical use of the drug gammalon in children with cerebral palsy].
    Sazonova NS; Balashova EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(10):1464-8. PubMed ID: 4154691
    [No Abstract]   [Full Text] [Related]  

  • 4. [The GABOB in pediatric neuropsychiatry. Indications and results].
    Cavazzuti GB
    Clin Ter; 1969 Mar; 48(6):515-24. PubMed ID: 5404652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of Encephabol in child neuropsychiatry].
    Dubois B; Balmelle J; Fontaine G
    Lille Med; 1970 Nov; ():Suppl 6:1348+. PubMed ID: 5502909
    [No Abstract]   [Full Text] [Related]  

  • 6. [Attempts of treatment with geriocaine in cases of cerebral palsy].
    Jaroszewicz L; Szpotowicz E; Tyszkiewicz M; de Walden J
    Psychiatr Neurol Med Psychol Beih; 1968; 8-9():148-52. PubMed ID: 5006372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tryptophan metabolism research in oligophrenic children. 4.: Activity and possibility of activating hepatic kynureninase after vitamin B6 treatment].
    Grimm U; Knapp A; Schmitz W; Smetan M; Schmitz KW; Reddemann H; Schulz M; Schlenska K
    Psychiatr Neurol Med Psychol (Leipz); 1975 Nov; 27(11):675-81. PubMed ID: 1215441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dipiperon treatment in a psychiatric out-patient clinic for children and youths].
    Müller-Küppers M
    Acta Paedopsychiatr; 1971; 38(2):40-6. PubMed ID: 4942603
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the clinical pharmacology of an association of gamma-amino-beta-hydroxybutyric acid and plant extracts used in therapy of children with behavior disorders and sleep disorders].
    Cavazzuti GB
    Clin Ter; 1969 Oct; 51(1):15-29. PubMed ID: 5370056
    [No Abstract]   [Full Text] [Related]  

  • 10. [First results with Calbion in the psychosomatic treatment of exceptional children].
    Vincze RM
    Hospital (Rio J); 1967 Sep; 72(3):765-70. PubMed ID: 5304633
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trial of sulpiride in child psychiatry].
    Kohler C; Marcon G; Maritan C
    Rev Neuropsychiatr Infant; 1971 Dec; 19(12):751-8. PubMed ID: 5138771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and clinical picture of oligophrenia among students with cerebral palsy].
    Mastiukova EM; Pevzner MS; Peresleni LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):386-9. PubMed ID: 3705848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gammalon in the rehabilitation in infantile cerebral palsy].
    Gershman RN; Vasilenko MA; Iliushina GG; Iakimenko GD; Iakovleva SM
    Pediatr Akus Ginekol; 1977 Dec; (6):26-7. PubMed ID: 343053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regenerating action of highly polymerized desoxyribonucleic acid on the handicapped with multiple deficiencies (intellectual, motor and hypotrophic) in childhood].
    Brauner F; Kohler C; Vallée J
    Bull Acad Natl Med; 1971 Jul; 155(23):565-9. PubMed ID: 4256872
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the clinical effects of sulpiride in medico-pedgogic day-school and day hospital for children].
    Lang JL; Le Strat M
    Rev Neuropsychiatr Infant; 1971 Dec; 19(12):759-72. PubMed ID: 5138772
    [No Abstract]   [Full Text] [Related]  

  • 16. Breath-holding spells and vitamin B6.
    Abecasis MK
    Dev Med Child Neurol; 1973 Aug; 15(4):541. PubMed ID: 4732908
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime.
    Rankin PM; Harrison S; Chong WK; Boyd S; Aylett SE
    Dev Med Child Neurol; 2007 Apr; 49(4):300-5. PubMed ID: 17376142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statistical analysis of the results obtained with prolonged treatment with gamma-amino-beta-hydroxybutyric acid of character disorders].
    Ferro-Milone F; Toschi P; Lorizio A
    Riv Neurobiol; 1966; 12(3):267-97. PubMed ID: 4860044
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of behavior scales and urinary homovanillic acid determinations in monitoring the combined treatment with vitamin B6 and magnesium of children displaying autistic behavior].
    Barthélémy C; Garreau B; Leddet I; Sauvage D; Muh JP; Lelord G; Callaway E
    Neuropsychiatr Enfance Adolesc; 1983; 31(5-6):289-301. PubMed ID: 6888687
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot study with RO 5-4556 in emotionally disturbed retarded children.
    Ucer E
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):187-95. PubMed ID: 4967223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.